To any project manager, team member, sponsor, supplier, and stakeholder, it might seem trivial to say that “effective project management is more important than ever before.” However, in 2024, that would likely be an understatement. …
Read more
2024 has already been a year of significant transformation for New Jersey Innovation Institute. This transformational trend started last summer and as the pace accelerates, it continues to spur growth and opportunity. NJII has a …
Read more
Newark, NJ – January 10, 2024 — New Jersey Innovation Institute (NJII), a New Jersey Institute of Technology (NJIT) subsidiary, today announced two additions to the leadership team — Michael van Ter Sluis has been …
Read more
New Jersey Innovation Institute (NJII) has appointed Michael Edmondson, Ph.D. as its Vice President for Continued Learning to oversee the Professional & Corporate Education division. Edmondson also serves as the Associate Provost for Continued Learning at …
Read more
New Jersey Innovation Institute (NJII) has appointed Tom Nehila as its Chief Financial Officer. Previously working as NJII’s interim CFO, Nehila was offered the full-time position after demonstrating his strategic leadership and helping to transform …
Read more
The NJ Social Determinants of Health Hackathon Will Showcase Innovations to Help At-Risk Populations Newark, NJ (October 25, 2023) – New Jersey Innovation Institute (NJII), a New Jersey Institute of Technology (NJIT) subsidiary, is partnering …
Read more
The New Jersey Innovation Institute (NJII), a corporation of New Jersey Institute of Technology (NJIT), is pleased to announce the appointment of Dr. Michael Johnson as NJII President. Johnson emerged from a deep and talented …
Read more
CMS Medicaid Enterprise System certification will ensure continuity of health services to New Jersey populations and further health innovation efforts from New Jersey Health Information Network. Newark, NJ (March 27, 2023) – New Jersey Innovation …
Read more
HITRUST Risk-based, 2-year Certification validates New Jersey Innovation Institute is committed to consistently and effectively meeting key regulations and protecting sensitive information. Newark, New Jersey (December 9, 2022) – New Jersey Innovation Institute (NJII), a …
Read more
New Jersey Innovation Institute (NJII) announced the sale of its subsidiary, BioCentriq Inc., to GC corp. for $73 million. BioCentriq manufactures autologous and allogeneic cell therapies and gene therapies and specializes in viral vector production, cell and viral banking, and upstream and downstream processing.
Read more
This year ROI-NJ presents the first-ever ROI Influencers Technology list which includes New Jersey Tech Leaders in various categories. Dr. Joel Bloom, president, NJIT and Chairman of NJII Board of Directors and Nariman Farvardin, president, …
Read more
NJII welcomes three new members to its board of Directors from Newark Venture Partners, NJ Hospital Association and Girls with Impact.
Read more